Legal News

UK re-opens pharma probes after coronavirus (COVID-19) delays

Published on: 22 July 2020
Published by a Law360 reporter

Article summary

Law360, London: The UK’s antitrust enforcer on 20 July 2020 resumed probes of allegedly anti-competitive market allocation agreements for two drugs used to treat urinary tract infections and nausea, after the investigations largely stalled this spring amid delays due to the novel coronavirus (COVID-19) pandemic.

Popular documents